Large-cap Healthcare company West Pharmaceutical Services has logged a -0.4% change today on a trading volume of 189,161. The average volume for the stock is 497,478.
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Based in Exton, the company has 10,065 full time employees and a market cap of $16,319,068,160.
The company is now trading -39.59% away from its average analyst target price of $364.83 per share. The 6 analysts following the stock have set target prices ranging from $285 to $449, and on average give West Pharmaceutical Services a rating of buy.
Over the last year, WST shares have gone down by -48.5%, which represents a difference of -31.2% when compared to the S&P 500. The stock's 52 week high is $475 per share and its 52 week low is $206.19. Based on West Pharmaceutical Services's average gross margin growth of 9.5% over the last four years, its core business remains strong and the stock price may recover in the long term.
If you would like a free fundamental analysis of West Pharmaceutical Services and other stocks that interest you, subscribe to our free newsletter!